Frank Essmann
5PUBLICATIONS
26CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Mar 18, 2026
KLF5 controls subtype-independent highly interactive enhancers in pancreatic cancer to regulate cell survival.Thomas L Ekstrom, Zhangshuai Dai, Julia Thiel
|Jul 24, 2024
BCL-2 and BOK regulate apoptosis by interaction of their C-terminal transmembrane domains.Tobias B Beigl, Alexander Paul, Thomas P Fellmeth
|Apr 21, 2022
The BCL-2 inhibitor ABT-199/venetoclax synergizes with proteasome inhibition via transactivation of the MCL-1 antagonist NOXA.Sandra Weller, Astrid Toennießen, Benjamin Schaefer
|Jul 27, 2021
BH3-only protein expression determines hepatocellular carcinoma response to sorafenib-based treatment.Stephanie Busche, Katharina John, Franziska Wandrer
|Aug 26, 2020
The BCL-2 selective inhibitor ABT-199 sensitizes soft tissue sarcomas to proteasome inhibition by a concerted mechanism requiring BAX and NOXA.Alina Muenchow, Sandra Weller, Clemens Hinterleitner
Pageof 1
Frequent Collaborators
2 joint publications
Klaus Schulze-Osthoff
1 joint publications
Ulrich Lehmann
1 joint publications
Tobias B Beigl
1 joint publications
Alexander Paul
1 joint publications
Thomas P Fellmeth
1 joint publications
Dang Nguyen
1 joint publications
Lynn Barber
1 joint publications
Sandra Weller
1 joint publications
Benjamin Schäfer
1 joint publications
Bernhard F Gillissen
